We have previously demonstrated that directing TNFα-CSG to tumor ECM triggers immune cell infiltration which in turn delivers a cocktail of ECM-degrading proteases leading to specific tumor ECM breakdown (5). The gene discussed is TNF; the disease is neoplasm.